Tenax Therapeutics (TENX) Treasury Shares (2012 - 2018)

Tenax Therapeutics (TENX) reported Treasury Shares of $19914.0 for Q4 2018, little changed sequentially from $19914.0 in Q3 2018.

Tenax Therapeutics (TENX) Treasury Shares (2012 - 2018) Analysis & Trends

Tenax Therapeutics (TENX) has 7 years of Treasury Shares data on file, last reported at $19914.0 in Q4 2018.

For the quarter ending Q4 2018, Treasury Shares changed N/A year-over-year to $19914.0; the trailing twelve-month figure through Dec 2018 stood at $19914.0 (changed N/A YoY), and the FY2018 full-year result was $19914.0, changed N/A from the prior year.
Treasury Shares was little changed at $19914.0 in Q4 2018, from $19914.0 in the prior quarter.
In the past five years, Treasury Shares ranged from a high of $42629.0 in Q1 2014 to a low of $12.0 in Q4 2016.
A 5-year average of $11932.5 and a median of $367.0 in 2016 frame the typical range for Treasury Shares.
Across the five-year window, Treasury Shares soared 2115.86% in 2014 and tumbled 99.79% in 2015, its largest moves.
Tracing TENX's Treasury Shares over 5 years: stood at $229.0 in 2014, then plunged by 91.27% to $20.0 in 2015, then slumped by 40.0% to $12.0 in 2016, then soared by 783.33% to $106.0 in 2017, then soared by 18686.79% to $19914.0 in 2018.
Business Quant data shows TENX's Treasury Shares at $19914.0 in Q4 2018, $19914.0 in Q3 2018, and $39828.0 in Q2 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-21,709.08
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	265,401.92
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	19.41 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	5.14 Mn
10	Tenax Therapeutics	67,856.40	67,856.40	-	-

Download Data